Cargando…
Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
The quality of life, in itself, in cancer patients or in osteoporotic individuals, without even considering the side effects of the medication in the first place, has a considerable negative impact on the clinical outcome. The Medication Related Osteonecrosis of the Jaw (MRONJ), in the maxillofacial...
Autores principales: | Al Abdullateef, Abdulrhman, Alhareky, Muhanad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292880/ https://www.ncbi.nlm.nih.gov/pubmed/32550810 http://dx.doi.org/10.1016/j.jsps.2020.05.004 |
Ejemplares similares
-
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021) -
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021) -
Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023) -
Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
por: AlRowis, Raed, et al.
Publicado: (2022)